CRISPR

$115.74
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$4.64 (-3.85%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell CRISPR and other stocks, options, and ETFs commission-free!

About CRSP

CRISPR Therapeutics AG engages in the development and commercialization of therapies derived from genome-editing technology. Its proprietary platform CRISPR/Cas9-based therapeutics allows for precise and directed changes to genomic DNA.

CEO
Samarth Kulkarni
Employees
410
Headquarters
Zug, Zug
Founded
2014
Market Cap
8.82B
Price-Earnings Ratio
Dividend Yield
Average Volume
1.24M
High Today
$119.37
Low Today
$114.32
Open Price
$119.28
Volume
1.07M
52 Week High
$220.20
52 Week Low
$42.83

CRSP Earnings

-$1.50
-$0.20
$1.10
$2.40
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
per share
Actual
Expected Apr 27, After Hours

You May Also Like

ASB-D
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure